Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
01 2NURAY CHEMICALS PRIVATE LIMITED
02 1Biophore India Pharmaceuticals Pvt. Ltd
03 1Neuland Laboratories Limited
04 1Aurobindo Pharma Limited
05 1Catalent Micron Technologies, Inc.
06 1Glenmark Life Sciences Limited
07 1MSN Laboratories Private Limited
08 1Pfizer Asia Manufacturing Pte Ltd
09 2Pfizer Ireland Pharmaceuticals Unlimited Company
10 1TAPI Croatia Industries Ltd.
01 1TAFAMIDIS (FORM-4)
02 10Tafamidis
03 1Tafamidis (CC)
01 7India
02 4U.S.A
03 1Blank
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
NDC Package Code : 58159-079
Start Marketing Date : 2020-06-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
NDC Package Code : 73435-031
Start Marketing Date : 2022-12-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
Neuland Laboratories- A dedicated 100% API provider.
NDC Package Code : 58032-1031
Start Marketing Date : 2023-03-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
NDC Package Code : 58159-090
Start Marketing Date : 2022-07-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66039-960
Start Marketing Date : 2022-02-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-743
Start Marketing Date : 2024-01-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14501-0102
Start Marketing Date : 2020-03-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60715-0647
Start Marketing Date : 2018-10-31
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60715-4344
Start Marketing Date : 2018-10-31
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 11722-081
Start Marketing Date : 2024-12-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
75
PharmaCompass offers a list of Tafamidis API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tafamidis manufacturer or Tafamidis supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tafamidis manufacturer or Tafamidis supplier.
PharmaCompass also assists you with knowing the Tafamidis API Price utilized in the formulation of products. Tafamidis API Price is not always fixed or binding as the Tafamidis Price is obtained through a variety of data sources. The Tafamidis Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid, including repackagers and relabelers. The FDA regulates 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid supplier is an individual or a company that provides 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid active pharmaceutical ingredient (API) or 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid finished formulations upon request. The 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid suppliers may include 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid suppliers with NDC on PharmaCompass.
We have 8 companies offering 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid
Get in contact with the supplier of your choice:
